New VD [Subject Characteristics].[CONSORTIUM]
New VD [Subject Characteristics].[DISEASE_GROUP]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML1031:Arm A HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML1031:Arm A LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML1031:Arm B HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML1031:Arm B LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML1031:Arm C]
New VD [Subject Characteristics].[TREATMENT_ARM].[AEIOP LAM 2002:ICE-ICE-AVE-HAM- HD-AraC/SR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AEIOP LAM 2002:ICE-ICE-AVE-HAM-SCT/HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:Arm A HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:Arm A LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:Arm B HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[AAML0531:Arm B LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:ADE-ADE-MACE-CLASP-MidAC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:ADE-ADE-MACE-CLASP-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:ADE-ADE-MACE-MidAC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:ADE-ADE-MACE-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:ADE-ADE-off trial]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:MAE-MAE-MACE-CLASP-MidAC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:MAE-MAE-MACE-CLASP-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:MAE-MAE-MACE-MidAC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:MAE-MAE-MACE-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML12:MAE-MAE-Off Trial]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-MACE-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-MACE-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-MACE/Mytolarg-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-MACE/Mytolarg-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-MACE-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-MACE-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-MACE/Mytolarg-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-MACE/Mytolarg-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-AraC3g-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-AraC3g-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-AraC3g/Mytolarg-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE-ADE-AraC3g/Mytolarg-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-AraC3g-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-AraC3g-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-AraC3g/Mytolarg-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:ADE/Mytolarg-ADE-AraC3g/Mytolarg-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-MACE-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-MACE-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-MACE/Mytolarg-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-MACE/Mytolarg-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE/Mytolarg-MidAC-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-MACE/Mytolarg-MidAC-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-AraC3g-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-AraC3g-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-AraC3g/Mytolarg-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda-FLAGIda-AraC3g/Mytolarg-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g/Mytolarg-AraC3g-AraC]
New VD [Subject Characteristics].[TREATMENT_ARM].[MRC AML15:FLAGIda/Mytolarg-FLAGIda-AraC3g/Mytolarg-AraC3g-No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2004:AIET-AM-HA1M-HA2E-HA3-HA2E + Gemtuzumab Ozagamicin]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2004:AIET-AM-HA1M-HA2E-HA3-HA2E + No Further Therapy]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-HAM-HA3E-FLA]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC-ADE-HAM-HA3E-FLA]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD-HAM-HA3E-FLA]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-HAM-HA3E-FLA]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-HA3E-FLA (Low Risk)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -ADE-HA3E-FLA (Low Risk)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD-HA3E-FLA (Low Risk)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-HA3E-FLA (Low Risk)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-HAM + SCT (High Risk 1)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -ADE-HAM + SCT (High Risk 1)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD-HAM + SCT (High Risk 1)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-HAM + SCT (High Risk 1)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-HAM-HA3E + SCT (High Risk 2)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -ADE-HAM-HA3E+ SCT (High Risk 2)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD-HAM-HA3E+ SCT (High Risk 2)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-HAM-HA3E+ SCT (High Risk 2)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-HAM-HA3E-FLA + SCT (High Risk 3)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -ADE-HAM-HA3E-FLA + SCT (High Risk 3)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD-HAM-HA3E-FLA + SCT (High Risk 3)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-HAM-HA3E-FLA + SCT (High Risk 3)]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-ADE-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -ADE-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:MEC-FLAD- Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[NOPHO AML 2012:DEC -FLAD-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Post Recovery AM-HA2E+HA3+HA2E]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Post Recovery FLA/Dnx-HA2E+HA3+HA2E]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Post Recovery AM-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Post Recovery FLA/Dnx-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Immediate AM-HA2E+HA3+HA2E]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Immediate  FLA/Dnx-HA2E+HA3+HA2E]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Immediate  AM-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[DB - AML01:AIET-Immediate  FLA/Dnx-Off Protocol]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + Consolidation]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + Consolidation]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + Consolidation + AUTO/ALLO SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + Consolidation + AUTO/ALLO SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(3+5+10) + AUTO/ALLO SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AIEOP LAM 92:ICE(3+5+10) + ICE(2+3+7) + AUTO/ALLO SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[SCFE ELAM02:Induction + Consolidation 1 + Consolidation 2 + Consolidation 3]
New VD [Subject Characteristics].[TREATMENT_ARM].[SCFE ELAM02:Induction + Consolidation 1 + Consolidation 2 + Consolidation 3 + IL2 Maintenance]
New VD [Subject Characteristics].[TREATMENT_ARM].[SCFE ELAM02:Induction + Consolidation 1 + Allo HSCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE- AI-haM-HAE- Standard maintenance, 12 Gy (Standard Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE- AI-haM-HAE- Standard maintenance, 18 Gy (Standard Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE- AI-haM-HAE- Standard maintenance, 12 Gy (Standard Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE- AI-haM-HAE- Standard maintenance, 18 Gy(Standard Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI/2CDA-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI-haM, HAE- Standard maintenance, 12 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI-haM, HAE- Standard maintenance, 18 Gy (High Risk arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI-haM, SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:AIE-HAM- AI/2CDA-haM, SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI-haM, SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML-BFM 2004:ADxE-HAM- AI/2CDA-haM, SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM Registry 2012:ADxE- AI-haM-HAE- Standard Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM Registry 2012:ADxE-HAM- AI-haM, HAE- Standard Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM Registry 2012:ADxE-HAM- AI-haM, SCT (High Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- AI-haM, AI- HAE -Short Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- AI-haM, AI- HAE - Standard Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- HAM- AI- haM-HAE -Short Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- HAM- AI- haM-HAE -Standard Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE - AI-haM, AI- HAE -Short Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE - AI-haM, AI- HAE - Standard Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE - HAM- AI- haM-HAE -Short Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE - HAM- AI- haM-HAE -Standard Maintenance (Standard Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA-HAM- AI-haM- HAE-Short Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA-HAM- AI-haM- HAE -Standard Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE- HAM- AI-haM- HAE-Short Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE- HAM- AI-haM- HAE-Standard Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Short Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Standard Maintenance (Intermediate Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Stem Cell Transplantation (High Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:CDxA-HAM, AI, haM, Stem Cell Transplantation(High Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE- HAM Sorafenib, AI Sorafenib, haM Sorafenib, Stem Cell Transplantation (High Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[AML BFM 2012:ADxE- HAM, AI, haM, Stem Cell Transplantation (High Risk Arm)]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:HDAC-ADE+GO-C1-C2-C3]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:HDAC-ADE-C1-C2-C3]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:HDAC-ADE+GO-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:HDAC-ADE-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:LDAC-ADE+GO-C1-C2-C3]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:LDAC-ADE-C1-C2-C3]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:LDAC-ADE+GO-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[SJCRH AML02:LDAC-ADE-SCT]
New VD [Subject Characteristics].[TREATMENT_ARM].[PPLLSG AML-98:SR]
New VD [Subject Characteristics].[TREATMENT_ARM].[PPLLSG AML-98:HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[JACLS AML99:LR]
New VD [Subject Characteristics].[TREATMENT_ARM].[JACLS AML99:IR]
New VD [Subject Characteristics].[TREATMENT_ARM].[JACLS AML99:HR]
New VD [Subject Characteristics].[TREATMENT_ARM].[JPLSG AML05:JACLS]
New VD [Time Period]
New VD [Time Period].[HONEST_BROKER_SUBJECT_ID]
New VD [Time Period].[SUBMITTER_ID]
New VD [Time Period].[PARENT_SUBMITTER_ID]
New VD [Time Period].[TIME_PERIOD_TYPE]
New VD [Time Period].[TIME_PERIOD_TYPE].[Disease Phase]
New VD [Time Period].[TIME_PERIOD_TYPE].[Course]
New VD [Time Period].[DISEASE_PHASE]
New VD [Time Period].[COURSE]
New VD [Time Period].[TIME_PERIOD_NUMBER]
New VD [Time Period].[YEAR_AT_START]
New VD [Time Period].[AGE_AT_START]
New VD [Time Period].[AGE_AT_END]
New VD [Off Protocol Therapy Or Study].[HONEST_BROKER_SUBJECT_ID]
New VD [Off Protocol Therapy Or Study].[TIME_PERIOD_SUBMITTER_ID]
New VD [Demographics].[HONEST_BROKER_SUBJECT_ID]
New VD [Medical History].[HONEST_BROKER_SUBJECT_ID]
New VD [Survival Characteristics].[HONEST_BROKER_SUBJECT_ID]
New VD [Survival Characteristics].[TIME_PERIOD_SUBMITTER_ID]
New VD [Vitals And Anthropometrics].[HONEST_BROKER_SUBJECT_ID]
New VD [Vitals And Anthropometrics].[TIME_PERIOD_SUBMITTER_ID]
New VD [Function Test].[HONEST_BROKER_SUBJECT_ID]
New VD [Function Test].[TIME_PERIOD_SUBMITTER_ID]
New VD [Laboratory Test].[HONEST_BROKER_SUBJECT_ID]
New VD [Laboratory Test].[TIME_PERIOD_SUBMITTER_ID]
New VD [Molecular Analysis].[HONEST_BROKER_SUBJECT_ID]
New VD [Molecular Analysis].[TIME_PERIOD_SUBMITTER_ID]
New VD [Diagnosis]
New VD [Diagnosis].[HONEST_BROKER_SUBJECT_ID]
New VD [Diagnosis].[AGE_AT_DIAG_ASSESSMENT]
New VD [Diagnosis].[TIME_PERIOD_SUBMITTER_ID]
New VD [Diagnosis].[DIAGNOSIS_BASIS]
New VD [Diagnosis].[DIAGNOSIS]
New VD [Disease Site Assessment]
New VD [Disease Site Assessment].[HONEST_BROKER_SUBJECT_ID]
New VD [Disease Site Assessment].[AGE_AT_SITE_ASSESSMENT]
New VD [Disease Site Assessment].[TIME_PERIOD_SUBMITTER_ID]
New VD [Medication].[HONEST_BROKER_SUBJECT_ID]
New VD [Medication].[TIME_PERIOD_SUBMITTER_ID]
New VD [Medication].[CATEGORY]
New VD [Medication].[ADMINISTRATION_STATUS]
New VD [Radiation Therapy].[HONEST_BROKER_SUBJECT_ID]
New VD [Radiation Therapy].[TIME_PERIOD_SUBMITTER_ID]
New VD [Transfusion Medicine Procedure].[HONEST_BROKER_SUBJECT_ID]
New VD [Transfusion Medicine Procedure].[TIME_PERIOD_SUBMITTER_ID]
New VD [Cellular Immunotherapy].[HONEST_BROKER_SUBJECT_ID]
New VD [Cellular Immunotherapy].[TIME_PERIOD_SUBMITTER_ID]
New VD [Stem Cell Transplant].[HONEST_BROKER_SUBJECT_ID]
New VD [Stem Cell Transplant].[TIME_PERIOD_SUBMITTER_ID]
New VD [Stem Cell Transplant].[SCT_TYPE].[Autologous, Single]
New VD [Stem Cell Transplant].[SCT_TYPE].[Autologous, Tandem]
New VD [Minimal Residual Disease].[HONEST_BROKER_SUBJECT_ID]
New VD [Minimal Residual Disease].[TIME_PERIOD_SUBMITTER_ID]
New VD [Minimal Residual Disease].[METHOD].[Flow Cytometry, Different-From-Normal]
New VD [Subject Response].[HONEST_BROKER_SUBJECT_ID]
New VD [Subject Response].[TIME_PERIOD_SUBMITTER_ID]
New VD [Adverse Events].[HONEST_BROKER_SUBJECT_ID]
New VD [Adverse Events].[TIME_PERIOD_SUBMITTER_ID]
New VD [Adverse Events].[AGE_AT_AE_RESOLVED]
New VD [Adverse Events].[AE_CODE_SYSTEM].[SNOMED]
New VD [Adverse Events].[AE_CODE_SYSTEM].[ICD]
New VD [Subsequent Malignant Neoplasm].[HONEST_BROKER_SUBJECT_ID]
New VD [Subsequent Malignant Neoplasm].[MORPH_CODE_SYSTEM]
New VD [Subsequent Malignant Neoplasm].[MORPH_CODE_SYSTEM_VERSION]
New VD [Subsequent Malignant Neoplasm].[TOP_CODE_SYSTEM]
New VD [Subsequent Malignant Neoplasm].[TOP_CODE_SYSTEM_VERSION]
Deprecated VD [Subject Identifier]
Deprecated VD [Subject Identifier].[PCDC_SUBJECT_ID]
Deprecated VD [Disease Phase Timing]
Deprecated VD [Course Timing]
Deprecated VD [Off Protocol Therapy/Study].[DISEASE_PHASE]
Deprecated VD [Off Protocol Therapy/Study].[DISEASE_PHASE_NUMBER]
Deprecated VD [Off Protocol Therapy/Study].[COURSE]
Deprecated VD [Off Protocol Therapy/Study].[COURSE_NUMBER]
Deprecated VD [Survival Characteristics].[DISEASE_PHASE]
Deprecated VD [Survival Characteristics].[DISEASE_PHASE_NUMBER]
Deprecated VD [Survival Characteristics].[COURSE]
Deprecated VD [Survival Characteristics].[COURSE_NUMBER]
Deprecated VD [Vitals].[DISEASE_PHASE]
Deprecated VD [Vitals].[DISEASE_PHASE_NUMBER]
Deprecated VD [Vitals].[COURSE]
Deprecated VD [Vitals].[COURSE_NUMBER]
Deprecated VD [Function Test].[DISEASE_PHASE]
Deprecated VD [Function Test].[DISEASE_PHASE_NUMBER]
Deprecated VD [Function Test].[COURSE]
Deprecated VD [Function Test].[COURSE_NUMBER]
Deprecated VD [Labs].[DISEASE_PHASE]
Deprecated VD [Labs].[DISEASE_PHASE_NUMBER]
Deprecated VD [Labs].[COURSE]
Deprecated VD [Labs].[COURSE_NUMBER]
Deprecated VD [Molecular Analysis].[DISEASE_PHASE]
Deprecated VD [Molecular Analysis].[DISEASE_PHASE_NUMBER]
Deprecated VD [Molecular Analysis].[COURSE]
Deprecated VD [Molecular Analysis].[COURSE_NUMBER]
Deprecated VD [Disease Characteristics].[DISEASE_PHASE]
Deprecated VD [Disease Characteristics].[DISEASE_PHASE_NUMBER]
Deprecated VD [Myeloid Sarcoma Involvement]
Deprecated VD [Total Dose].[DISEASE_PHASE]
Deprecated VD [Total Dose].[DISEASE_PHASE_NUMBER]
Deprecated VD [Total Dose].[COURSE]
Deprecated VD [Total Dose].[COURSE_NUMBER]
Deprecated VD [Radiation Therapy].[DISEASE_PHASE]
Deprecated VD [Radiation Therapy].[DISEASE_PHASE_NUMBER]
Deprecated VD [Radiation Therapy].[COURSE]
Deprecated VD [Radiation Therapy].[COURSE_NUMBER]
Deprecated VD [Transfusion Medicine Procedure].[DISEASE_PHASE]
Deprecated VD [Transfusion Medicine Procedure].[DISEASE_PHASE_NUMBER]
Deprecated VD [Transfusion Medicine Procedure].[COURSE]
Deprecated VD [Transfusion Medicine Procedure].[COURSE_NUMBER]
Deprecated VD [Cellular Immunotherapy].[DISEASE_PHASE]
Deprecated VD [Cellular Immunotherapy].[DISEASE_PHASE_NUMBER]
Deprecated VD [Cellular Immunotherapy].[COURSE]
Deprecated VD [Cellular Immunotherapy].[COURSE_NUMBER]
Deprecated VD [Concomitant Medication]
Deprecated VD [Stem Cell Transplant].[DISEASE_PHASE]
Deprecated VD [Stem Cell Transplant].[DISEASE_PHASE_NUMBER]
Deprecated VD [Stem Cell Transplant].[COURSE]
Deprecated VD [Stem Cell Transplant].[COURSE_NUMBER]
Deprecated VD [Minimal Residual Disease].[DISEASE_PHASE]
Deprecated VD [Minimal Residual Disease].[DISEASE_PHASE_NUMBER]
Deprecated VD [Minimal Residual Disease].[COURSE]
Deprecated VD [Minimal Residual Disease].[COURSE_NUMBER]
Deprecated VD [Adverse Events].[DISEASE_PHASE]
Deprecated VD [Adverse Events].[DISEASE_PHASE_NUMBER]
Deprecated VD [Adverse Events].[COURSE]
Deprecated VD [Adverse Events].[COURSE_NUMBER]
Deprecated VD [Secondary Malignant Neoplasm].[DISEASE_PHASE]
Deprecated VD [Secondary Malignant Neoplasm].[DISEASE_PHASE_NUMBER]
Deprecated VD [Secondary Malignant Neoplasm].[COURSE]
Deprecated VD [Secondary Malignant Neoplasm].[COURSE_NUMBER]
[aml_v1.7].[Disease Phase Timing].[DISEASE_PHASE] skos:exactMatch [aml_v2.0].[Time Period].[DISEASE_PHASE]
[aml_v1.7].[Course Timing].[COURSE] skos:exactMatch [aml_v2.0].[Time Period].[COURSE]
[aml_v1.7].[Disease Phase Timing].[DISEASE_PHASE_NUMBER] skos:broadMatch [aml_v2.0].[Time Period].[TIME_PERIOD_NUMBER]
[aml_v1.7].[Disease Phase Timing].[AGE_AT_DISEASE_PHASE] skos:broadMatch [aml_v2.0].[Time Period].[AGE_AT_START]
[aml_v1.7].[Disease Phase Timing].[YEAR_AT_DISEASE_PHASE] skos:broadMatch [aml_v2.0].[Time Period].[YEAR_AT_START]
[aml_v1.7].[Course Timing].[COURSE_NUMBER] skos:broadMatch [aml_v2.0].[Time Period].[TIME_PERIOD_NUMBER]
[aml_v1.7].[Course Timing].[AGE_AT_COURSE_START] skos:broadMatch [aml_v2.0].[Time Period].[AGE_AT_START]
[aml_v1.7].[Course Timing].[AGE_AT_COURSE_END] skos:exactMatch [aml_v2.0].[Time Period].[AGE_AT_END]
[aml_v1.7].[Course Timing].[AGE_AT_COURSE_ANC_500] skos:exactMatch [aml_v2.0].[Time Period].[AGE_AT_COURSE_ANC_500]
[aml_v1.7].[Off Protocol Therapy/Study] skos:exactMatch [aml_v2.0].[Off Protocol Therapy Or Study]
[aml_v1.7].[Medical History].[MEDICAL_HISTORY] skos:exactMatch [aml_v2.0].[Medical History].[CONDITION]
[aml_v1.7].[Vitals] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics]
[aml_v1.7].[Vitals].[AGE_AT_VITALS] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics].[AGE_AT_MEASUREMENT]
[aml_v1.7].[Vitals].[VITALS_TEST] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics].[MEASUREMENT_TYPE]
[aml_v1.7].[Vitals].[VITALS_RESULT] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics].[RESULT_TEXT]
[aml_v1.7].[Vitals].[VITALS_RESULT_NUMERIC] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics].[RESULT_NUMERIC]
[aml_v1.7].[Vitals].[VITALS_RESULT_UNIT] skos:exactMatch [aml_v2.0].[Vitals And Anthropometrics].[RESULT_UNIT]
[aml_v1.7].[Function Test].[FUNCTION_CATEGORY] skos:exactMatch [aml_v2.0].[Function Test].[TEST]
[aml_v1.7].[Function Test].[FUNCTION_TEST] skos:exactMatch [aml_v2.0].[Function Test].[MEASUREMENT_TYPE]
[aml_v1.7].[Function Test].[FUNCTION_RESULT] skos:exactMatch [aml_v2.0].[Function Test].[RESULT_TEXT]
[aml_v1.7].[Function Test].[FUNCTION_RESULT_NUMERIC] skos:exactMatch [aml_v2.0].[Function Test].[RESULT_NUMERIC]
[aml_v1.7].[Function Test].[FUNCTION_RESULT_UNIT] skos:exactMatch [aml_v2.0].[Function Test].[RESULT_UNIT]
[aml_v1.7].[Labs] skos:exactMatch [aml_v2.0].[Laboratory Test]
[aml_v1.7].[Labs].[LAB_CATEGORY] skos:exactMatch [aml_v2.0].[Laboratory Test].[CATEGORY]
[aml_v1.7].[Labs].[LAB_TEST] skos:exactMatch [aml_v2.0].[Laboratory Test].[TEST]
[aml_v1.7].[Labs].[LAB_SPEC_TYPE] skos:exactMatch [aml_v2.0].[Laboratory Test].[SPECIMEN]
[aml_v1.7].[Labs].[LAB_METHOD] skos:exactMatch [aml_v2.0].[Laboratory Test].[METHOD]
[aml_v1.7].[Labs].[LAB_RESULT] skos:exactMatch [aml_v2.0].[Laboratory Test].[RESULT_TEXT]
[aml_v1.7].[Labs].[LAB_RESULT_NUMERIC] skos:exactMatch [aml_v2.0].[Laboratory Test].[RESULT_NUMERIC]
[aml_v1.7].[Labs].[LAB_RESULT_UNIT] skos:exactMatch [aml_v2.0].[Laboratory Test].[RESULT_UNIT]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M0] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M0]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M1]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M2] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M2]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M3] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M3]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M3 Variant] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M3 Variant]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M4] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M4]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M4eo] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M4eo]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M5] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M5]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M6] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M6]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[M7] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[M7]
[aml_v1.7].[Disease Characteristics].[FAB_TYPE].[AML, NOS] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[AML, NOS]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[AML, Not Otherwise Specified] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[AML, NOS]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with t(8;21)(q22;q22.1); RUNX1-RUNX1T1]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> APL with PML-RARA] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> APL with PML-RARA]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with t(9;11)(p21.3;q23.3); KMT2A-MLLT3]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 5 >> AML with KMT2A Rearrangement] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 5 >> AML with KMT2A Rearrangement]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with t(6;9)(p23;q34.1);DEK-NUP214] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with t(6;9)(p23;q34.1);DEK-NUP214]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2); GATA2, MECOM]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML (megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Provisional Entity: AML with BCR-ABL1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Provisional Entity: AML with BCR-ABL1]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Mutated NPM1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with Mutated NPM1]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Biallelic Mutations of CEBPA] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with Biallelic Mutations of CEBPA]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Provisional Entity: AML with Mutated RUNX1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Provisional Entity: AML with Mutated RUNX1]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Myelodysplasia-related Changes] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with Myelodysplasia-related Changes]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Therapy-Related Myeloid Neoplasms] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Therapy-Related Myeloid Neoplasms]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Minimal Differentiation] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with Minimal Differentiation]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML without Maturation] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML without Maturation]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> AML with Maturation] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> AML with Maturation]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Myelomonocytic Leukemia] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Acute Myelomonocytic Leukemia]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Monoblastic/Monocytic Leukemia] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Acute Monoblastic/Monocytic Leukemia]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Pure Erythroid Leukemia] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Pure Erythroid Leukemia]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Megakaryoblastic Leukemia] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Acute Megakaryoblastic Leukemia]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Basophilic Leukemia] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Acute Basophilic Leukemia]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Acute Panmyelosis with Myelofibrosis] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Acute Panmyelosis with Myelofibrosis]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Sarcoma] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Myeloid Sarcoma]
[aml_v1.7].[Myeloid Sarcoma Involvement].[MYELOID_SARCOMA].[Yes] skos:exactMatch [aml_v2.0].[Diagnosis].[WHO > Version 4 >> Myeloid Sarcoma]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Proliferations Related to Down Syndrome] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Myeloid Proliferations Related to Down Syndrome]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Transient Abnormal Myelopoiesis (TAM)] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[WHO >> Version 4 >> Transient Abnormal Myelopoiesis (TAM)]
[aml_v1.7].[Disease Characteristics].[WHO_AML].[WHO >> Version 4 >> Myeloid Leukemia Associated with Down Syndrome] skos:exactMatch [aml_v2.0].[Diagnosis].[WHO >> Version 4 >> Myeloid Leukemia Associated with Down Syndrome]
[aml_v1.7].[Disease Characteristics].[CNS_DISEASE_STATUS] skos:broadMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS]
[aml_v1.7].[Disease Characteristics].[CNS_DISEASE_STATUS].[CNS1] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[CNS1]
[aml_v1.7].[Disease Characteristics].[CNS_DISEASE_STATUS].[CNS2] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[CNS2]
[aml_v1.7].[Disease Characteristics].[CNS_DISEASE_STATUS].[CNS3] skos:exactMatch [aml_v2.0].[Diagnosis].[DIAGNOSIS].[CNS3]
[aml_v1.7].[Disease Characteristics].[MPAL] skos:exactMatch [aml_v2.0].[Diagnosis].[MPAL]
[aml_v1.7].[Disease Characteristics].[MLDS] skos:exactMatch [aml_v2.0].[Diagnosis].[MLDS]
[aml_v1.7].[Disease Characteristics].[TAM] skos:exactMatch [aml_v2.0].[Diagnosis].[TAM]
[aml_v1.7].[Disease Characteristics].[SECONDARY_AML] skos:exactMatch [aml_v2.0].[Diagnosis].[SECONDARY_AML]
[aml_v1.7].[Disease Characteristics].[DETECTION_METHOD] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[DETECTION_METHOD]
[aml_v1.7].[Disease Characteristics].[DISEASE_SITE] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE]
[aml_v1.7].[Myeloid Sarcoma Involvement].[MYELOID_SARCOMA_SITE].[Bone] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Bone]
[aml_v1.7].[Myeloid Sarcoma Involvement].[MYELOID_SARCOMA_SITE].[Orbit] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Orbit]
[aml_v1.7].[Myeloid Sarcoma Involvement].[MYELOID_SARCOMA_SITE].[Skin] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Skin]
[aml_v1.7].[Disease Characteristics].[DISEASE_SITE].[Bone Marrow] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Bone Marrow]
[aml_v1.7].[Disease Characteristics].[DISEASE_SITE].[Central Nervous System] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Central Nervous System]
[aml_v1.7].[Disease Characteristics].[DISEASE_SITE].[Testes] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE].[Testes]
[aml_v1.7].[Disease Characteristics].[SITE] skos:exactMatch [aml_v2.0].[Disease Site Assessment].[SITE]
[aml_v1.7].[Total Dose] skos:exactMatch [aml_v2.0].[Medication]
[aml_v1.7].[Total Dose].[AGE_AT_TOTAL_DOSE_START] skos:exactMatch [aml_v2.0].[Medication].[AGE_AT_MEDICATION_START]
[aml_v1.7].[Total Dose].[AGE_AT_TOTAL_DOSE_END] skos:exactMatch [aml_v2.0].[Medication].[AGE_AT_MEDICATION_END]
[aml_v1.7].[Total Dose].[ANTINEOPLASTIC_AGENT] skos:exactMatch [aml_v2.0].[Medication].[MEDICATION]
[aml_v1.7].[Radiation Therapy].[RT_SITE] skos:exactMatch [aml_v2.0].[Radiation Therapy].[SITE]
[aml_v1.7].[Radiation Therapy].[RT_DOSE] skos:exactMatch [aml_v2.0].[Radiation Therapy].[DOSE]
[aml_v1.7].[Radiation Therapy].[RT_UNIT] skos:exactMatch [aml_v2.0].[Radiation Therapy].[DOSE_UNIT]
[aml_v1.7].[Transfusion Medicine Procedure].[TMP_TYPE] skos:exactMatch [aml_v2.0].[Transfusion Medicine Procedure].[TYPE]
[aml_v1.7].[Transfusion Medicine Procedure].[TMP_PRODUCT] skos:exactMatch [aml_v2.0].[Transfusion Medicine Procedure].[PRODUCT]
[aml_v1.7].[Cellular Immunotherapy].[CIMT_TYPE] skos:exactMatch [aml_v2.0].[Cellular Immunotherapy].[TYPE]
[aml_v1.7].[Concomitant Medication].[MEDICATION].[Dexrazoxane] skos:exactMatch [aml_v2.0].[Medication].[MEDICATION].[Dexrazoxane]
[aml_v1.7].[Stem Cell Transplant].[SCT_TYPE].[Autologous] skos:exactMatch [aml_v2.0].[Stem Cell Transplant].[SCT_TYPE].[Autologous, NOS]
[aml_v1.7].[Stem Cell Transplant].[SCT_SOURCE] skos:exactMatch [aml_v2.0].[Stem Cell Transplant].[STEM_CELL_SOURCE]
[aml_v1.7].[Stem Cell Transplant].[SCT_DONOR_RELATIONSHIP] skos:exactMatch [aml_v2.0].[Stem Cell Transplant].[DONOR_RELATIONSHIP]
[aml_v1.7].[Stem Cell Transplant].[SCT_CONDITIONING_TYPE] skos:exactMatch [aml_v2.0].[Stem Cell Transplant].[CONDITIONING_TYPE]
[aml_v1.7].[Stem Cell Transplant].[SCT_TBI] skos:exactMatch [aml_v2.0].[Stem Cell Transplant].[PRIOR_TBI]
[aml_v1.7].[Minimal Residual Disease].[MRD_METHOD] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[METHOD]
[aml_v1.7].[Minimal Residual Disease].[MRD_METHOD].[Flow Cytometry] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[METHOD].[Flow Cytometry, NOS]
[aml_v1.7].[Minimal Residual Disease].[MRD_METHOD].[Molecular Real-Time Quantitative Polymerase Chain Reaction] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[METHOD].[Molecular Real-time Quantitative PCR]
[aml_v1.7].[Minimal Residual Disease].[FLOW_CYTOMETRY_TYPE].[Leukemia-Associated Immunophenotypes] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[METHOD].[Flow Cytometry, Leukemia-Associated Immunophenotypes]
[aml_v1.7].[Minimal Residual Disease].[MRD_RESULT] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[RESULT_TEXT]
[aml_v1.7].[Minimal Residual Disease].[MRD_RESULT_NUMERIC] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[RESULT_NUMERIC]
[aml_v1.7].[Minimal Residual Disease].[MRD_RESULT_UNIT] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[RESULT_UNIT]
[aml_v1.7].[Minimal Residual Disease].[MRD_SENSITIVTY] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[SENSITIVITY]
[aml_v1.7].[Minimal Residual Disease].[MRD_SAMPLE_SOURCE] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[SPECIMEN]
[aml_v1.7].[Minimal Residual Disease].[MRD_MOLECULAR_MARKERS] skos:exactMatch [aml_v2.0].[Minimal Residual Disease].[MOLECULAR_MARKERS]
[aml_v1.7].[Adverse Events].[AE_SYSTEM] skos:exactMatch [aml_v2.0].[Adverse Events].[AE_CODE_SYSTEM]
[aml_v1.7].[Adverse Events].[AE_GRADE] skos:exactMatch [aml_v2.0].[Adverse Events].[GRADE]
[aml_v1.7].[Adverse Events].[AE_ATTRIBUTION] skos:exactMatch [aml_v2.0].[Adverse Events].[ATTRIBUTION]
[aml_v1.7].[Adverse Events].[AE_OUTCOME] skos:exactMatch [aml_v2.0].[Adverse Events].[OUTCOME]
[aml_v1.7].[Adverse Events].[AE_ICU] skos:exactMatch [aml_v2.0].[Adverse Events].[ICU]
[aml_v1.7].[Adverse Events].[AE_MEDICATION] skos:exactMatch [aml_v2.0].[Adverse Events].[SUPPORTIVE_MEDICATION]
[aml_v1.7].[Adverse Events].[AE_INTERVENTION] skos:exactMatch [aml_v2.0].[Adverse Events].[INTERVENTION_STATUS]
[aml_v1.7].[Adverse Events].[AE_MED_INTERVENTION_DETAIL] skos:exactMatch [aml_v2.0].[Adverse Events].[INTERVENTION]
[aml_v1.7].[Secondary Malignant Neoplasm] skos:exactMatch [aml_v2.0].[Subsequent Malignant Neoplasm]
[aml_v1.7].[Secondary Malignant Neoplasm].[SMN_ICD_O_MORPH] skos:exactMatch [aml_v2.0].[Subsequent Malignant Neoplasm].[MORPH_CODE]
[aml_v1.7].[Secondary Malignant Neoplasm].[SMN_ICD_O_TOP] skos:exactMatch [aml_v2.0].[Subsequent Malignant Neoplasm].[TOP_CODE]
